UAE becomes first in world to approve new oral vitiligo drug
Dubai: The UAE has once again positioned itself at the forefront of global healthcare innovation, becoming the first country in the world to approve an expanded use of the drug RINVOQ (upadacitinib) for treating non-segmental vitiligo, a skin condition that causes patches of skin to lose their colour. The Emirates Drug Establishment (EDE) on Monday announced that it has approved a new therapeutic…
We haven't written up this one. Gulf News has the full story — the link below goes straight to it.
